Status:
COMPLETED
Effects of Ranibizumab in Primary Pterygium Surgery
Lead Sponsor:
Universiti Sains Malaysia
Conditions:
Patients With Primary Nasal Pterygium
Eligibility:
All Genders
40-80 years
Phase:
PHASE1
Brief Summary
Pterygium is a common ocular surface disease in Malaysia. Without treatment, it can lead to severe visual impairment. Recurrence is the commonest complication and novel treatment approaches are crucia...
Detailed Description
This is a prospective interventional study conducted from May 2018 to April 2020. Patients with primary pterygium who attended eye clinic Hospital Universiti Sains Malaysia (HUSM) Kubang Kerian, Kelan...
Eligibility Criteria
Inclusion
- primary nasal grade 2 to 3 pterygium based on the clinical stages outlined by Johnston et al (2004)
- who consented for pterygium excision and conjunctival autograft surgery
Exclusion
- cornea pathology such as scarring, history of herpetic keratitis, eyelid abnormalities, previous ocular surgery, ocular trauma, and ocular or systemic inflammatory disease
- Pregnant women and lactating mothers
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2020
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04878835
Start Date
May 1 2018
End Date
April 30 2020
Last Update
May 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universiti Sains Malaysia
Kota Bharu, Kelantan, Malaysia, 16150